Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,
[[thumbnail_alt_text]]
A new blood test for Alzheimer disease could provide a more sensitive, accurate indicator of plaques and tangles corresponding to the disease in living people.
[[thumbnail_alt_text]]
Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.
[[thumbnail_alt_text]]
Research may address the lack of effective treatments for mental fatigue among patients with multiple sclerosis.
[[thumbnail_alt_text]]
Spinal muscular atrophy is the leading genetic cause of death in infants. 


 
[[thumbnail_alt_text]]
The combination medication is used to treat the symptoms of tension or muscle contraction headaches. The drug is only available via a prescription from a physician.
[[thumbnail_alt_text]]
New molecules could the brain’s immune system to better control epilepsy.  

 
[[thumbnail_alt_text]]
Tofersen proves safe in clinical trials in the treatment of amyotrophic lateral sclerosis.
[[thumbnail_alt_text]]
The study concluded that pharmacists reportedly scored higher on the knowledge test than neurologists and nurse practitioners.
[[thumbnail_alt_text]]
Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.
[[thumbnail_alt_text]]
Low back pain is one of the leading reasons people seek medical care and the number 1 cause of disability globally.
[[thumbnail_alt_text]]
The key to better outcomes for patients with MS is to address it early.